Madrigal Pharmaceuticals Inc.https://investorshangout.com/Madrigal-Pharmaceuticals-Inc-MDGL-92761/en-usThu, 03 Sep 2026 03:42:46 GMTCopyright InvestorsHangout.comwhytestocks: $MDGL News Article - Got $2,000? 3 Growth Stocks to Buy That Could Double Your Money https://investorshangout.com/post/view?id=6648516https://investorshangout.com/post/view?id=6648516Thu, 30 Nov 2023 18:30:52 GMTwhytestocks: $MDGL News Article - 1 Beaten-Down Stock That Could Soar by 86%, According to Wall Street https://investorshangout.com/post/view?id=6620490https://investorshangout.com/post/view?id=6620490Wed, 20 Sep 2023 12:45:45 GMTwhytestocks: $MDGL News Article - Madrigal Pharmaceuticals Inc. (NASDAQ: MDGL) is a Leading Gainer in 9/13 Morninhttps://investorshangout.com/post/view?id=6618066https://investorshangout.com/post/view?id=6618066Wed, 13 Sep 2023 15:40:47 GMTwhytestocks: $MDGL News Article - Madrigal Pharmaceuticals Announces Rolling Submission of New Drug Application thttps://investorshangout.com/post/view?id=6591686https://investorshangout.com/post/view?id=6591686Fri, 30 Jun 2023 14:30:53 GMTwhytestocks: $MDGL News Article - Madrigal Pharmaceuticals Presents Phase 3 MAESTRO-NASH Data During the Opening https://investorshangout.com/post/view?id=6588474https://investorshangout.com/post/view?id=6588474Thu, 22 Jun 2023 14:55:46 GMTwhytestocks: $MDGL News Article - Why Madrigal Pharmaceuticals Stock Is Marching Higher Today https://investorshangout.com/post/view?id=6578554https://investorshangout.com/post/view?id=6578554Wed, 24 May 2023 17:40:46 GMTwhytestocks: $MDGL News Article - Madrigal Receives Breakthrough Therapy Designation from FDA for Resmetirom and https://investorshangout.com/post/view?id=6562744https://investorshangout.com/post/view?id=6562744Tue, 18 Apr 2023 14:45:47 GMTwhytestocks: $MDGL News Article - Madrigal Pharmaceuticals Provides Corporate Updates and Reports 2022 Fourth Quahttps://investorshangout.com/post/view?id=6540728https://investorshangout.com/post/view?id=6540728Thu, 23 Feb 2023 20:40:52 GMTwhytestocks: $MDGL News Article - Why Madrigal Pharmaceuticals Was a Top Stock This Week https://investorshangout.com/post/view?id=6514493https://investorshangout.com/post/view?id=6514493Fri, 23 Dec 2022 13:50:47 GMTznewcar1: $MDGL 268% v8,8M c234.83 f17,103M H236.39 ML57.21 YL60.75 Gap>200 https://investorshangout.com/post/view?id=6512466https://investorshangout.com/post/view?id=6512466Mon, 19 Dec 2022 22:50:59 GMTwhytestocks: $MDGL News Article - Madrigal Pharmaceuticals Initiates the MAESTRO-NASH Outcomes Study Evaluating Rhttps://investorshangout.com/post/view?id=6463790https://investorshangout.com/post/view?id=6463790Wed, 31 Aug 2022 18:25:53 GMTAviseAnalytics: WILL RESMETIROM PROVE TO BE A GAMECHANGER IN NASH? $MDGL Madrigal Pharmaceuticalhttps://investorshangout.com/post/view?id=6336126https://investorshangout.com/post/view?id=6336126Fri, 04 Feb 2022 12:50:31 GMTwhytestocks: $MDGL News Article - Dominic F. Labriola Joins Madrigal Pharmaceuticals as Chief Data and Analytics https://investorshangout.com/post/view?id=6318042https://investorshangout.com/post/view?id=6318042Mon, 10 Jan 2022 17:35:50 GMTwhytestocks: $MDGL News Article - Madrigal Pharmaceuticals Provides Corporate Update and Reports 2021 Third Quarthttps://investorshangout.com/post/view?id=6276902https://investorshangout.com/post/view?id=6276902Thu, 04 Nov 2021 12:25:56 GMTwhytestocks: $MDGL News Article - Madrigal Pharmaceuticals to Present Additional Analyses of Data from The Phase https://investorshangout.com/post/view?id=5407845https://investorshangout.com/post/view?id=5407845Mon, 08 Apr 2019 18:30:41 GMTwhytestocks: $MDGL News Article - NetworkNewsBreaks - BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT) Apphttps://investorshangout.com/post/view?id=5382678https://investorshangout.com/post/view?id=5382678Mon, 18 Mar 2019 16:35:40 GMTznewcar1: 0531 ->144% 5M C265.61 WOW WLhttps://investorshangout.com/post/view?id=5071222https://investorshangout.com/post/view?id=5071222Sat, 02 Jun 2018 03:14:38 GMT